Pathophysiology of Euglycemic DKA in SGLT2 Inhibitors • Kidney: Glycosuria, Natriuresis, ↑ Ketone bodies reabsorption • Pancreas: ↓ Insulin secretion, ↑ Glucagon secretion • Adipose tissue: ↑ Lipolysis • Liver: ß-oxidation, ↑ Ketogenesis → Euglycemic DKA Dr priti MD @priti899 #Euglycemic #DKA #SGLT2i #Inhibitors #pathophysiology #nephrology